Sentences with phrase «virus therapy»
"Virus therapy" refers to using viruses to treat diseases. In this type of treatment, certain viruses are altered or engineered to target and eliminate specific harmful cells or medical conditions in the body. The idea is to use these viruses as a tool to fight and cure diseases. Full definition
Our team was instrumental in the development of talimogene laherparepvec, the first in human oncolytic virus therapy for patients with melanoma.
roswellpark.org
Oncolytic virus therapy uses a modified virus that can cause tumor cells to self - destruct and generate a greater immune response against the cancer.
The FDA has approved its first oncolytic virus therapy talimogene laherparepvec (Imlygic), a drug for the treatment of patients with melanoma lesions in the skin and lymph nodes.
I'm a recurrent thyroid cancer patient undergoing oncolytic virus therapy, lcurrently ooking at Keytruda or Avelumab as next line of therapy once immunogenic cell death has occurred.
Ongoing research aims to enhance the effectiveness of oncolytic virus therapy and broaden its applicability.
Current immunotherapies for brain cancer fall into six broad categories: cancer vaccines, checkpoint inhibitors, oncolytic virus therapy, adoptive cell therapy, adjuvant immunotherapies, and monoclonal antibodies.
Current immunotherapy approaches for melanoma fall into seven main categories: checkpoint inhibitors, oncolytic virus therapies, cancer vaccines, adjuvant immunotherapy, adoptive cell therapy, monoclonal antibodies, and cytokines.
The first three drugs are checkpoint inhibitors that «take the brakes off» the immune system and enable it to fight cancer; the last is an oncolytic virus therapy that stimulates stronger anti-tumor immune responses.
In 2015, another type of immunotherapy — oncolytic virus therapy — was approved for the local treatment of unresectable cutaneous, subcutaneous, and nodal lesions in patients with melanoma that has recurred after initial surgery.
Current experimental immunotherapies for prostate cancer fall into seven broad categories: therapeutic vaccines, oncolytic virus therapies, checkpoint inhibitors, adoptive cell therapies, adjuvant immunotherapies, cytokines, and monoclonal antibodies.
These treatments can be broken into 4 main categories: checkpoint inhibitors / immune modulators, monoclonal antibodies, adoptive cell transfer, and oncolytic virus therapy.
Current immunotherapies for colorectal cancer fall into seven broad categories: checkpoint inhibitors and immune modulators, monoclonal antibodies, therapeutic vaccines, adoptive cell therapy, oncolytic virus therapy, adjuvant immunotherapies, and cytokines.
Vyriad, a biopharmaceutical company in Rochester, Minnesota, developed this technology and is led by Stephen Russell, M.D., Ph.D., a professor of molecular medicine at the Mayo Clinic and an expert in oncolytic virus therapy.
Vyriad is a clinical stage, biopharmaceutical company based in Rochester, Minn., that specializes in the development of powerful oncolytic virus therapies, using engineered viruses designed to selectively and rapidly destroy cancer.
There are several different treatments being compared, including: surgery followed by vaccine - based immunotherapy, surgery followed by oncolytic virus therapy, surgery followed by IL - 12 gene therapy and biopsy followed by placement of a specialized catheter system that draws tumor cells out of the brain.